Retrophin, Inc. Intellectual Property Contracts & Agreements
15 Contracts & Agreements
- License Agreements (2 contracts)
- Trademark Agreements (13)
- Fifth Amendment to Trademark License and Supply Agreement dated as of September 30, 2020, between the Company and Mission Pharmacal Company (Filed With SEC on February 20, 2024)
- Amendment Two to the Third Amendment to Trademark License and Supply Agreement, dated November 3, 2017, by and between the Company and Mission Pharmacal Company (Filed With SEC on February 20, 2024)
- Amendment One to the Third Amendment to Trademark License and Supply Agreement, dated September 12, 2016, by and between the Company and Mission Pharmacal Company (Filed With SEC on February 20, 2024)
- Third Amendment to Trademark License and Supply Agreement dated as of March 17, 2016, between the Company and Mission Pharmacal Company (Filed With SEC on February 20, 2024)
- Trademark License and Supply Agreement, dated May 29, 2014, by and between the Company and Mission Pharmacal Company (Filed With SEC on February 20, 2024)
- Fifth Amendment to Trademark License and Supply Agreement, effective September 30, 2020, between the Company and Mission Pharmacal Company (Filed With SEC on November 5, 2020)
- Fourth Amendment to Trademark License and Supply Agreement dated as of November 28, 2018, between Retrophin Inc. and Mission Pharmacal (Filed With SEC on February 26, 2019)
- Amendment Two to the Third Amendment to Trademark License and Supply Agreement, dated November 3, 2017, by and between the Company and Mission Pharmacal Company (Filed With SEC on February 27, 2018)
- AMENDMENT ONE TO THE THIRD AMENDMENT TO TRADEMARK LICENSE AND SUPPLY AGREEMENT (Filed With SEC on November 4, 2016)
- THIRD AMENDMENT TO TRADEMARK LICENSE AND SUPPLY AGREEMENT (Filed With SEC on May 5, 2016)
- SECOND AMENDMENT TO TRADEMARK LICENSE AND SUPPLY AGREEMENT (Filed With SEC on May 5, 2016)
- FIRST AMENDMENT TO TRADEMARK LICENSE AND SUPPLY AGREEMENT (Filed With SEC on July 29, 2014)
- Trademark License & Supply Agreement (Filed With SEC on June 4, 2014)
- EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on December 18, 2013)
- LICENSE AGREEMENT between NOVARTIS PHARMA AG NOVARTIS AG and RETROPHIN, INC. Table of Contents (Filed With SEC on December 18, 2013)
